Literature DB >> 19436493

Chemical and biophysical insights into the propagation of prion strains.

Jeppe Falsig, K Peterr Nilsson, Tuomas P J Knowles, Adriano Aguzzi.   

Abstract

Transmissible spongiform encephalopathies (TSEs) are lethal infectious neurodegenerative diseases. TSEs are caused by prions, infectious agents lacking informational nucleic acids, and possibly identical with higher-order aggregates of the cellular glycolipoprotein PrP(C). Prion strains are derived from TSE isolates that, even after inoculation into genetically identical hosts, cause disease with distinct patterns of protein aggregate deposition, incubation times, morphology of the characteristic brain damage, and cellular tropism. Most of these traits are relatively stable across serial passages. Here we review current techniques for studying prion strain differences in vivo and in cells, and discuss the strain phenomena in the general context of the knowledge gained from modeling prion fibril growth in vitro and in simple organisms.

Entities:  

Year:  2008        PMID: 19436493      PMCID: PMC2645583          DOI: 10.2976/1.2990786

Source DB:  PubMed          Journal:  HFSP J        ISSN: 1955-205X


  100 in total

1.  Imaging distinct conformational states of amyloid-beta fibrils in Alzheimer's disease using novel luminescent probes.

Authors:  K Peter R Nilsson; Andreas Aslund; Ina Berg; Sofie Nyström; Peter Konradsson; Anna Herland; Olle Inganäs; Frantz Stabo-Eeg; Mikael Lindgren; Gunilla T Westermark; Lars Lannfelt; Lars N G Nilsson; Per Hammarström
Journal:  ACS Chem Biol       Date:  2007-08-03       Impact factor: 5.100

2.  The energy landscapes and motions of proteins.

Authors:  H Frauenfelder; S G Sligar; P G Wolynes
Journal:  Science       Date:  1991-12-13       Impact factor: 47.728

Review 3.  A 'unified theory' of prion propagation.

Authors:  C Weissmann
Journal:  Nature       Date:  1991-08-22       Impact factor: 49.962

4.  Prion generation in vitro: amyloid of Ure2p is infectious.

Authors:  Andreas Brachmann; Ulrich Baxa; Reed Brendon Wickner
Journal:  EMBO J       Date:  2005-08-11       Impact factor: 11.598

Review 5.  Prion diseases of humans and animals: their causes and molecular basis.

Authors:  J Collinge
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

6.  Mice devoid of PrP are resistant to scrapie.

Authors:  H Büeler; A Aguzzi; A Sailer; R A Greiner; P Autenried; M Aguet; C Weissmann
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

Review 7.  Transmissible spongiform encephalopathies.

Authors:  Steven J Collins; Victoria A Lawson; Colin L Masters
Journal:  Lancet       Date:  2004-01-03       Impact factor: 79.321

Review 8.  Antiprion immunotherapy: to suppress or to stimulate?

Authors:  Adriano Aguzzi; Christina J Sigurdson
Journal:  Nat Rev Immunol       Date:  2004-09       Impact factor: 53.106

9.  Role of intermolecular forces in defining material properties of protein nanofibrils.

Authors:  Tuomas P Knowles; Anthony W Fitzpatrick; Sarah Meehan; Helen R Mott; Michele Vendruscolo; Christopher M Dobson; Mark E Welland
Journal:  Science       Date:  2007-12-21       Impact factor: 47.728

10.  Protein-only transmission of three yeast prion strains.

Authors:  Chih-Yen King; Ruben Diaz-Avalos
Journal:  Nature       Date:  2004-03-18       Impact factor: 49.962

View more
  11 in total

1.  Nuclease resistant circular DNAs copurify with infectivity in scrapie and CJD.

Authors:  Laura Manuelidis
Journal:  J Neurovirol       Date:  2010-12-07       Impact factor: 2.643

2.  Analyses of protease resistance and aggregation state of abnormal prion protein across the spectrum of human prions.

Authors:  Daniela Saverioni; Silvio Notari; Sabina Capellari; Ilaria Poggiolini; Armin Giese; Hans A Kretzschmar; Piero Parchi
Journal:  J Biol Chem       Date:  2013-07-29       Impact factor: 5.157

3.  Generating Bona Fide Mammalian Prions with Internal Deletions.

Authors:  Carola Munoz-Montesino; Christina Sizun; Mohammed Moudjou; Laetitia Herzog; Fabienne Reine; Jérôme Chapuis; Danica Ciric; Angelique Igel-Egalon; Hubert Laude; Vincent Béringue; Human Rezaei; Michel Dron
Journal:  J Virol       Date:  2016-07-11       Impact factor: 5.103

4.  Nucleated polymerization with secondary pathways. I. Time evolution of the principal moments.

Authors:  Samuel I A Cohen; Michele Vendruscolo; Mark E Welland; Christopher M Dobson; Eugene M Terentjev; Tuomas P J Knowles
Journal:  J Chem Phys       Date:  2011-08-14       Impact factor: 3.488

5.  The non-core regions of human lysozyme amyloid fibrils influence cytotoxicity.

Authors:  Maria F Mossuto; Anne Dhulesia; Glyn Devlin; Erica Frare; Janet R Kumita; Patrizia Polverino de Laureto; Mireille Dumoulin; Angelo Fontana; Christopher M Dobson; Xavier Salvatella
Journal:  J Mol Biol       Date:  2010-07-17       Impact factor: 5.469

6.  The emergence of superstructural order in insulin amyloid fibrils upon multiple rounds of self-seeding.

Authors:  Weronika Surmacz-Chwedoruk; Viktoria Babenko; Robert Dec; Piotr Szymczak; Wojciech Dzwolak
Journal:  Sci Rep       Date:  2016-08-25       Impact factor: 4.379

7.  Amyloidogenic cross-seeding of Tau protein: Transient emergence of structural variants of fibrils.

Authors:  Bartosz Nizynski; Hanna Nieznanska; Robert Dec; Solomiia Boyko; Wojciech Dzwolak; Krzysztof Nieznanski
Journal:  PLoS One       Date:  2018-07-19       Impact factor: 3.240

Review 8.  Aβ Seeding as a Tool to Study Cerebral Amyloidosis and Associated Pathology.

Authors:  Marina Friesen; Melanie Meyer-Luehmann
Journal:  Front Mol Neurosci       Date:  2019-10-02       Impact factor: 5.639

9.  Detection and control of prion diseases in food animals.

Authors:  Peter Hedlin; Ryan Taschuk; Andrew Potter; Philip Griebel; Scott Napper
Journal:  ISRN Vet Sci       Date:  2012-02-29

Review 10.  A closer look at prion strains: characterization and important implications.

Authors:  Laura Solforosi; Michela Milani; Nicasio Mancini; Massimo Clementi; Roberto Burioni
Journal:  Prion       Date:  2013-01-28       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.